Current neurology and neuroscience reports · 2026
When to Start Oral Anticoagulant Therapy Post-Stroke: From Common to Rare Conundrums.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Budinčević Hrvoje, Črnac Petra, Meštrović Andrija, Ernoić Marija, Vogrinc Dora, Poje Juraj Mark, Penić Sandra Zečević, Vujović Sandra
Аннотация
PURPOSE OF REVIEW: This review summarizes recent evidence on when to start oral anticoagulant therapy following stroke, including both common and rare clinical conundrums.
RECENT FINDINGS: While previous recommendations based on Diener's rule suggested waiting up to 12 days based on stroke severity and neuroradiological findings, newer data support earlier initiation or resumption of anticoagulation, particularly for mild and moderate ischemic strokes, generally within 4 days. In patients with a history of intracerebral hemorrhage, anticoagulation resumption involves weighing thromboembolic risk against recurrent hemorrhage risk, requiring individualized decisions regarding whether and when anticoagulation should be resumed. Clinical recommendations for post-stroke anticoagulation emphasize early, individualized initiation of direct oral anticoagulants for mild-to-moderate ischemic strokes based on neuroimaging. After intracerebral hemorrhage, anticoagulation is generally restarted within 4 to 8 weeks for atrial fibrillation, with earlier resumption potentially warranted in selected high-thromboembolic-risk patients, particularly those with mechanical heart valves.
RECENT FINDINGS: While previous recommendations based on Diener's rule suggested waiting up to 12 days based on stroke severity and neuroradiological findings, newer data support earlier initiation or resumption of anticoagulation, particularly for mild and moderate ischemic strokes, generally within 4 days. In patients with a history of intracerebral hemorrhage, anticoagulation resumption involves weighing thromboembolic risk against recurrent hemorrhage risk, requiring individualized decisions regarding whether and when anticoagulation should be resumed. Clinical recommendations for post-stroke anticoagulation emphasize early, individualized initiation of direct oral anticoagulants for mild-to-moderate ischemic strokes based on neuroimaging. After intracerebral hemorrhage, anticoagulation is generally restarted within 4 to 8 weeks for atrial fibrillation, with earlier resumption potentially warranted in selected high-thromboembolic-risk patients, particularly those with mechanical heart valves.